Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-01-17
1996-05-21
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514183, 514212, 514218, 514256, 514315, 514357, 514385, 514602, 514605, 435183, 435184, A01N 4106, A01N 4300, A61K 3118, A61K 3133
Patent
active
055190600
ABSTRACT:
Methods are provided for using 2-hydroxy-3-aminopropylsulfonamides to mimic peptides and to modulate the chemical and/or biological activity of enzymes, particularly proteolytic enzymes. Also provided are compositions comprising the sulfonamides in admixture with a pharmaceutically acceptable carrier, adjuvant, or vehicle.
REFERENCES:
patent: 5444060 (1995-08-01), Urushibata et al.
patent: 5455258 (1995-10-01), MacPherson et al.
Askin, D. et al., "Highly Diasteroselective Reaction of Chiral, Non-Racemic Amide Enolate with (s)-Glycidyl Tosylate. Synthesis of the Orally Active HIV-1 Protease Inhibitor L-735,524", Tetrahedron Letters 1994, 35, 673-676.
Cheng, Y.-S. et al., "Stability and Activity of Human Immunodeficiency Virus Protease: Comparison of the Natural Dimer with a Homologous, Single-Chain Tethered Dimer", PNAS USA 1990, 87, 9660-9664.
Dorsey, B. et al., "L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor", J. of Med. Chem. 1994, 37 (21), 3443-3451.
Gallo, R. et al., "Frequent Detection and Isolation of Cytophatic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS", Science 1984, 224, 500-503.
Heimbach, J. et al., "Affinity Purification of the HIV-1 Protease", Biochem. and Biophys. Res. Comm. 1989, 164(3), 955-960.
Krohn, A. et al., "Novel Binding Mode of Highly Potent HIV-Proteinase Inhibitors Incorporating the (R)-Hydroxyethylamine Isostere", J. Med. Chem. 1991, 34, 3340-3342.
The Merck Index, Eleventh Edition, Budavari, et al. Eds., pp. 1403-1414, Merck & Co., Inc., New Jersey, 1989.
Miyoshi, I. et al., "Type C Virus Particles in a Cord T-Cell Line Derived by Co-Cultivating Normal Human Cord Leukocytes and Human Leukaemic T Cells", Nature 1981, 294, 770-771.
Popovic, M. et al., "Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-Aids", Science 1984, 224, 497-500.
Roberts, N. et al., "Rational Design of Peptide-Based HIV Proteinase Inhibitors", Science 1990, 248, 358-361.
Sarngadharan, M. G. et al., "Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS", Science 1984, 224, 506-508.
Schupach, J. et al., "Serlogical Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS", Science 1984, 224, 503-505.
Thompson, W. et al., "Synthesis and Antiviral Activity of a Series of HIV-1 Protease Inhibitors with Functionality Tethered to the P.sup.1 or P.sup.1, Phenyl Substituents: X-ray Crystal Structure Assisted Design", J. Med. Chem. 1992, 35, 1685-1701.
Zhang, Z.-Y. et al., "Dissociative Inhibtion of Dimeric Enzymes", The J. of Biol. Chem. 1991, 266(24), 15591-15594.
Hirschmann Ralph F.
Smith, III Amos B.
Sprengeler Paul
Yokoyama Akihisa
Nutter Nathan M.
The Trustees of the University of Pennsylvania
LandOfFree
Sulfonamide-based compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide-based compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide-based compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038418